Product Information
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Ascend Laboratories, LLC, priced at $0.6505 per EA under NDC 67877028001. Its NADAC has been published 278 times since Mar 3, 2021.
Strength
5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877028001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA203740On Market Since
11/13/2020
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has been published 278 times since Mar 3, 2021, and over the history we have for it it has declined 76.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6505 per EA |
|---|---|
| All-time high | $2.8001 (Mar 10, 2021) |
| All-time low | $0.6505 (Jun 17, 2026) |
| 52-week high | $0.9577 |
| 52-week low | $0.6505 |
| Median price | $1.2552 |
| Average price | $1.3827 |
| Largest weekly change | -47.1% (Jul 21, 2021) |
| Weeks tracked | 278 |
| Tracking since | Mar 3, 2021 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Ascend Laboratories, LLC, is $0.6505 per EA (NDC 67877028001), effective Jun 24, 2026.
How has the price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has declined 76.8%. It has been tracked across 278 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Mar 3, 2021, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.6505 (Jun 17, 2026) to a high of $2.8001 (Mar 10, 2021), with a median of $1.2552 per EA.
Are there cheaper alternatives to TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 67877028001) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification